Showing 1 - 10 of 10
Persistent link: https://www.econbiz.de/10003449162
Persistent link: https://www.econbiz.de/10003908978
Persistent link: https://www.econbiz.de/10002370467
Persistent link: https://www.econbiz.de/10008316277
This paper compares the innovation performance of established pharmaceutical firms and biotech companies, controlling for differences in the scale and scope of research. We develop a structural model to analyze more than 3,000 drug R&D projects advanced to pre-clinical and clinical trials in the...
Persistent link: https://www.econbiz.de/10008501715
This paper measures differences in the innovation performance of different types of firms in the pharmaceutical industry. We compare the innovation performance of incumbent firms with entrants, controlling for differences in the scale and scope of research, both at the firm level and at the...
Persistent link: https://www.econbiz.de/10005061689
This paper explored an unusually comprehensive dataset of more than 2,000 drug R&D projects all over the world during the 1990s. This enabled us to characterise several features of the innovation process in pharmaceuticals, particularly the different role and comparative R&D performance of the...
Persistent link: https://www.econbiz.de/10005034980
This paper compares the innovation performance of established pharmaceutical firms and biotech companies, controlling for differences in the scale and scope of research. We develop a structural model to analyze more than 3,000 drug research and development projects advanced to preclinical and...
Persistent link: https://www.econbiz.de/10009191729
Persistent link: https://www.econbiz.de/10001746243
The report examines the competitive position of the European pharmaceutical companies and industries, and compares them with the pharmaceutical companies and industries in other parts of the world, particularly the US. Over the last two decades, the industry has experienced some important...
Persistent link: https://www.econbiz.de/10005034968